Revance Therapeutics, Inc. (NASDAQ:RVNC) Q4 2021 Earnings Conference Call February 28, 2022 4:30 PM ET Company Participants Jessica Serra - Head, IR & and ESG Mark Foley - CEO Dustin Sjuts - President Toby Schilke - CFO Conference Call Participants Ken Cacciatore - Cowen and Company Alena Seamus Fernandez - Guggenheim David Amsellem - Piper Sandler Annabel Samimy - Stifel Balaji Prasad - Barclays Tim Lugo - William Blair Douglas Tsao - H.C. Wainwright Serge Belanger - Needham & Company Disclaimer*: This tra ...